Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141191 |
| CAS No | NA |
| Mol.F. | C14H14N4O |
| Mol.Wt. | 254.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141192 |
| CAS No | NA |
| Mol.F. | C22H29ClN4O |
| Mol.Wt. | 401.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141193 |
| CAS No | NA |
| Mol.F. | C18H18ClN3O |
| Mol.Wt. | 327.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141194 |
| CAS No | NA |
| Mol.F. | C18H19Cl2N3O |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141195 |
| CAS No | NA |
| Mol.F. | C14H8ClN3O2 |
| Mol.Wt. | 285.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141196 |
| CAS No | 41075-14-3 |
| Mol.F. | C14H10Cl2N2O |
| Mol.Wt. | 293.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141197 |
| CAS No | NA |
| Mol.F. | C6H5N5O3 |
| Mol.Wt. | 195.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141198 |
| CAS No | NA |
| Mol.F. | C10H10N4O4S |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141199 |
| CAS No | 131549-85-4 |
| Mol.F. | C10H9N3O4S |
| Mol.Wt. | 267.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141200 |
| CAS No | NA |
| Mol.F. | C6H8F3N5O2 |
| Mol.Wt. | 239.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141201 |
| CAS No | NA |
| Mol.F. | C6H8F3N5O2 |
| Mol.Wt. | 239.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141202 |
| CAS No | NA |
| Mol.F. | C20H18F6N6O6 |
| Mol.Wt. | 552.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141203 |
| CAS No | 16339-12-1 |
| Mol.F. | C2H6N2O2 |
| Mol.Wt. | 90.1 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141204 |
| CAS No | NA |
| Mol.F. | C20H19N9O7 |
| Mol.Wt. | 497.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141205 |
| CAS No | NA |
| Mol.F. | C17H23N3O6 |
| Mol.Wt. | 365.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141206 |
| CAS No | NA |
| Mol.F. | C24H29N9O6 |
| Mol.Wt. | 539.6 |
| INV STATUS | CUSTOM SYNTHESIS |